[Progress of acquired thrombotic thrombocytopenic purpura].
作者信息
Bao H Y, Qiao Y S, Wu D P
机构信息
Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2017 May 14;38(5):440-443. doi: 10.3760/cma.j.issn.0253-2727.2017.05.017.
Abstract
摘要
相似文献
1
[Progress of acquired thrombotic thrombocytopenic purpura].[获得性血栓性血小板减少性紫癜的研究进展]
Zhonghua Xue Ye Xue Za Zhi. 2017 May 14;38(5):440-443. doi: 10.3760/cma.j.issn.0253-2727.2017.05.017.
2
Current management of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的当前管理
Curr Opin Hematol. 2008 Sep;15(5):445-50. doi: 10.1097/MOH.0b013e328309ec62.
3
Acquired thrombotic thrombocytopenic purpura and pregnancy: More light than shade but controversies remain.获得性血栓性血小板减少性紫癜与妊娠：光明多于阴霾，但争议犹存。
Thromb Res. 2017 Aug;156:195-197. doi: 10.1016/j.thromres.2017.07.005. Epub 2017 Jul 5.
4
A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.一例以妊娠期血栓性血小板减少性紫癜为表现的严重ADAMTS13缺乏症病例。
Med Pregl. 2012 Sep-Oct;65(9-10):436-9. doi: 10.2298/mpns1210436n.
5
Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis.酷似急性脑膜脑炎的血栓性血小板减少性紫癜
Acta Clin Belg. 2011 Jan-Feb;66(1):55-6. doi: 10.2143/ACB.66.1.2062516.
6
Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why?检测疑似血栓性血小板减少性紫癜患者的ADAMTS13活性：何时、如何以及为何进行检测？
Transfusion. 2015 Jan;55(1):11-3. doi: 10.1111/trf.12885.
7
Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.在一名耶和华见证会成员中成功管理血栓性血小板减少性紫癜且未进行血浆置换
J Clin Apher. 2015 Feb;30(1):46-9. doi: 10.1002/jca.21325. Epub 2014 Apr 30.
8
The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura.辅助治疗在血栓性血小板减少性紫癜血浆置换中的作用。
Nephrol Dial Transplant. 2008 Aug;23(8):2701-2; author reply 2702-3. doi: 10.1093/ndt/gfn173. Epub 2008 Apr 10.
9
An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura.获得性血栓性血小板减少性紫癜的发病机制与治疗进展
Curr Opin Neurol. 2003 Jun;16(3):367-73. doi: 10.1097/01.wco.0000073939.19076.78.
10
Understanding organ dysfunction in thrombotic thrombocytopenic purpura.了解血栓性血小板减少性紫癜中的器官功能障碍。
Intensive Care Med. 2015 Apr;41(4):715-8. doi: 10.1007/s00134-014-3630-z. Epub 2015 Jan 20.
本文引用的文献
1
Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura.硼替佐米对复发/难治性获得性血栓性血小板减少性紫癜患者的治疗
Ann Hematol. 2016 Oct;95(11):1751-6. doi: 10.1007/s00277-016-2804-x. Epub 2016 Sep 3.
2
Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.硼替佐米用于难治性血栓性血小板减少性紫癜的治疗。
Br J Haematol. 2016 Jun;173(5):779-85. doi: 10.1111/bjh.13993. Epub 2016 Mar 24.
3
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.关于低剂量利妥昔单抗和血浆置换作为血栓性血小板减少性紫癜患者一线治疗方法的更多信息。
Hematology. 2016 Jun;21(5):311-6. doi: 10.1080/10245332.2015.1133008. Epub 2016 Feb 24.
4
Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.血栓性血小板减少性紫癜的非典型表现：ADAMTS13的诊断作用
J Thromb Thrombolysis. 2016 Aug;42(2):155-60. doi: 10.1007/s11239-016-1342-7.
5
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.卡普雷珠单抗治疗获得性血栓性血小板减少性紫癜。
N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533.
6
The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura.N-乙酰半胱氨酸在血栓性血小板减少性紫癜治疗中的作用。
J Thromb Thrombolysis. 2016 May;41(4):678-83. doi: 10.1007/s11239-015-1259-6.
7
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.在缓解后进行预防性利妥昔单抗输注可有效预防获得性血栓性血小板减少性紫癜的复发。
Blood. 2014 Jul 10;124(2):204-10. doi: 10.1182/blood-2014-01-550244. Epub 2014 May 28.
8
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜恢复后长期随访中出现多种主要合并症和死亡率增加。
Blood. 2013 Sep 19;122(12):2023-9; quiz 2142. doi: 10.1182/blood-2013-04-496752. Epub 2013 Jul 9.
9
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.一种模拟血栓性血小板减少性紫癜的新小鼠模型：重组人 ADAMTS13 可纠正其症状。
Blood. 2012 Jun 21;119(25):6128-35. doi: 10.1182/blood-2011-09-380535. Epub 2012 Apr 23.
10
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.一线利妥昔单抗治疗对血浆置换反应不佳的严重获得性血栓性血小板减少性紫癜的疗效和安全性。法国血栓性微血管病参考中心的经验。
Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.
Zotero 插件